Evidence brief · Supplement
Feverfew for Migraine frequency
Evidence grade C — Inconsistent
- Overall grade
- Grade C
- Last revised
- 1
- graded outcome
- 0
- references listed
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
1 at grade C — 1 graded row
What is known
Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.
- Migraine frequencyEvidence grade C
Inconsistent
Smallmixed
What is uncertain
Read off the same rows as above. Nothing here is added that the entry does not itself record.
- Thin evidence: Migraine frequency (grade C).
The evidence in words
The verdict
For migraine frequency, Feverfew earns evidence grade C (small effect, mixed consistency) — the evidence is limited or mixed. Inconsistent
How it might work
Anti-inflammatory and serotonin-modulating actions relevant to migraine pathophysiology.
How to use it
Standardized extract (parthenolide) daily for prevention; give it 1–2 months.
Safety & cautions
Generally tolerated; mouth ulcers with raw leaf; mild antiplatelet effect; rebound headaches on abrupt stop.
Bottom line
A modest migraine-prevention option, best stacked with magnesium and riboflavin. Standardized product, give it a couple of months.
How it is used
As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.
- Standard
- Standardized parthenolide daily, 1–2 months.
Goes with
- FeverfewRead the full Feverfew monographEvidence grade C
Related reading
Entries that share this one's tags or conditions.
- Feverfew for MigraineEvidence grade C — ProphylacticEvidence grade C
- Butterbur for MigraineEvidence grade B — PA-free onlyEvidence grade B
- Feverfew: dosage and how to take itStandardized parthenolide daily, 1–2 months.Evidence grade C
- Feverfew: side effects, safety & interactionsGenerally tolerated; mouth ulcers with raw leaf; mild antiplatelet effect; rebound headaches on abrupt stop.Evidence grade C
Sources
This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.
Last revised . A grade is this entry's reading of the evidence, not medical advice.